{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-24-025173","form_type":"8-K","ticker":"ADMA","cik":"0001368514","company_name":"ADMA BIOLOGICS, INC.","filed_at":"2024-05-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:18.112406+00:00","generated_at":"2026-06-02T05:16:52.082087+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"ADMA Biologics Q1 revenue $81.9M (+44% YoY); raises FY2024-25 guidance","bullets":["GAAP net income $17.8M vs net loss of $6.8M in prior year; adjusted EBITDA $26.4M, a 970% increase.","Gross margin improved to 48% from 29% YoY; working capital $223.3M, cash $45.3M.","FY2024 revenue guidance raised to >$355M (prior >$330M); net income >$85M (prior >$65M).","FY2025 revenue guidance raised to >$410M; adjusted EBITDA >$160M, up from >$140M."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-24-025173","json":"https://secwatch.observer/filing/0001140361-24-025173.json","markdown":"https://secwatch.observer/filing/0001140361-24-025173.md","text":"https://secwatch.observer/filing/0001140361-24-025173.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1368514/000114036124025173/0001140361-24-025173-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1368514/000114036124025173/ef20028782_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-02T05:16:52.082087+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"3bcfb2f36e086bbc778e55c23d5fc6347f35a466","claim":"ADMA BIOLOGICS, INC. reported three months ended March 31, 2024 results: revenue $81.9 Million, net income $17.8 Million. Guidance raised.","evidence_excerpt":"ADMA Biologics Announces First Quarter 2024 Financial Results and Provides Business Update 1Q 2024 Total Revenue of $81.9 Million, a 44% Increase Y-o-Y 1Q 2024 GAAP Net Income of $17.8 Million, a $24.6 Million Increase Y-o-Y","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1368514/000114036124025173/0001140361-24-025173-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"three months ended March 31, 2024"},{"label":"Revenue","value":"$81.9 Million"},{"label":"Net income","value":"$17.8 Million"},{"label":"Guidance","value":"raised"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}